source
- Hologic snaps up Reveal Genomics to boost genomic diagnostic reachHologic is acquiring precision oncology company Reveal Genomics.Fierce Biotech · 15h ago↗ source
- Genmab faces steep revenue cliff as Darzalex patents expire, eyes pivotal Epkinly readoutGenmab relies heavily on Darzalex, a cancer drug co‑developed with Johnson & Johnson, which currently provides about 90% of the company’s sales. U.S. patents for Darzalex are set to expire in 2029,…
- Researchers develop tumor "avatar" model that predicts immunotherapy response with 93% accuracy